Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial

• Egile Nagusiak: Yaoliang Lai (Egilea), Xiao Liang (Egilea), Heng Fan (Egilea), Yujin Liu (Egilea), Liang Zheng (Egilea), Weimin Lu (Egilea), Yuling Sun (Egilea), Dawei Huang (Egilea), Xingxing Liu (Egilea), Lijian Zhang (Egilea), Dongmei Zuo (Egilea), Zhexing Shou (Egilea), Qing Tang (Egilea), Yuanyuan Wang (Egilea), Zhen Li (Egilea), Zhengyan Jiang (Egilea), Shuo Zang (Egilea), Huisuo Huang (Egilea), Zongxiang Tang (Egilea), Qian Li (Egilea), Jun Xiao (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2022-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Diarrhea predominant irritable bowel syndrome (IBS) is a highly relapsing gastrointestinal disorder decreasing the quality of life. Existing studies indicated that the therapeutic effects maintained for a period of time after the treatments were discontinued (post-treatment therapeutic effects or PT...